{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:44:40Z","timestamp":1780472680128,"version":"3.54.1"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Vascular pathologies associated with SARS-CoV-2 infection are poorly understood. Color and sensory changes to the extremities, often referred to as \u201cCOVID toes\u201d or chilblains-like lesions, have been widely reported in children and adolescents since the onset of the pandemic, raising the concern that they could be a vasculitis secondary to the infection. However, it is unclear if the lesions are a result of the infection or an epiphenomenon. Most literature focuses on adults, and while there are reports on children and adolescents, many of them are small. This review will help medical care providers better understand the epidemiology, etiology, outcomes, and potential treatments for chilblains-like lesions seen in children and adolescents during the pandemic.<\/jats:p>","DOI":"10.3389\/fped.2022.904616","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T06:17:50Z","timestamp":1655965070000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Chilblains-Like Lesions in Pediatric Patients: A Review of Their Epidemiology, Etiology, Outcomes, and Treatment"],"prefix":"10.3389","volume":"10","author":[{"given":"Jessica","family":"Fennell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Onel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"751","DOI":"10.14423\/SMJ.0000000000001337","article-title":"COVID-19 Legacy","volume":"114","author":"Ladani","year":"2021","journal-title":"South Med J."},{"key":"B2","unstructured":"2022"},{"key":"B3","article-title":"Textbook of pediatric rheumatology","author":"Petty","year":"2021"},{"key":"B4","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2165\/11592190-000000000-00000","article-title":"Skin conditions in figure skaters, ice-hockey players and speed skaters: part II - cold-induced, infectious and inflammatory dermatoses","volume":"41","author":"Tlougan","year":"2011","journal-title":"Sports Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1525-1470.2000.01722.x","article-title":"Childhood pernio and cryoproteins","volume":"17","author":"Weston","year":"2000","journal-title":"Pediatr Dermatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/pde.14215","article-title":"Chilblains in children in the setting of COVID-19 pandemic","volume":"37","author":"Andina","year":"2020","journal-title":"Pediatr Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1001\/jamadermatol.2018.5077","article-title":"Assessment of clinical response to janus kinase inhibition in patients with familial chilblain lupus and TREX1 mutation","volume":"155","author":"Zimmermann","year":"2019","journal-title":"JAMA Dermatol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1038\/cti.2015.13","article-title":"Granzyme B mediated function of Parvovirus B19-specific CD4(+) T cells","volume":"4","author":"Kumar","year":"2015","journal-title":"Clin Transl Immunology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.3389\/fimmu.2019.02751","article-title":"Interferon-independent innate responses to cytomegalovirus","volume":"10","author":"Ashley","year":"2019","journal-title":"Front Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/bjd.19415","article-title":"The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series","volume":"184","author":"Magro","year":"2021","journal-title":"Br J Dermatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/pde.14566","article-title":"Acral Changes in pediatric patients during COVID 19 pandemic: registry report from the COVID 19 response task force of the society of pediatric dermatology (SPD) and pediatric dermatology research alliance (PeDRA)","volume":"38","author":"Castelo-Soccio","year":"2021","journal-title":"Pediatr Dermatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jaad.2020.06.019","article-title":"Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic","volume":"83","author":"Colonna","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.jaad.2020.08.021","article-title":"All that glisters is not COVID: Low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with chilblain-like lesions","volume":"83","author":"Denina","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1111\/jdv.16972","article-title":"Immunological and virological profile of children with chilblain-like lesions and SARS-CoV-2","volume":"35","author":"Fertitta","year":"2021","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1111\/jdv.16526","article-title":"Chilblain-like lesions during COVID-19 epidemic: a preliminary study on 63 patients","volume":"34","author":"Piccolo","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/bjd.19349","article-title":"No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain","volume":"183","author":"Caselli","year":"2020","journal-title":"Br J Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1080\/20477724.2021.1901040","article-title":"Cutaneous manifestations in a series of 417 patients with SARS-CoV-2 infection: epidemiological and clinical correlates of chilblain like lesions","volume":"115","author":"Brancaccio","year":"2021","journal-title":"Pathog Glob Health."},{"key":"B18","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/bjd.19327","article-title":"SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases","volume":"183","author":"Colmenero","year":"2020","journal-title":"Br J Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/pde.14210","article-title":"Chilblain-like lesions in children following suspected COVID-19 infection","volume":"37","author":"Colonna","year":"2020","journal-title":"Pediatr Dermatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/pde.14227","article-title":"Clustered cases of acral perniosis: clinical features, histopathology, and relationship to COVID-19","volume":"37","author":"Cordoro","year":"2020","journal-title":"Pediatr Dermatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1111\/jdv.16934","article-title":"Are SARS-CoV-2 IgA antibodies in paediatric patients with chilblain-like lesions indicative of COVID-19 asymptomatic or paucisymptomatic infection?","volume":"35","author":"Diociaiuti","year":"2021","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e2111369","DOI":"10.1001\/jamanetworkopen.2021.11369","article-title":"Bilateral chilblain-like lesions of the toes characterized by microvascular remodeling in adolescents during the COVID-19 Pandemic","volume":"4","author":"Discepolo","year":"2021","journal-title":"JAMA Netw Open."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e488","DOI":"10.1097\/INF.0000000000003274","article-title":"COVID Toes in three siblings","volume":"40","author":"Feder","year":"2021","journal-title":"Pediatr Infect Dis J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e14312","DOI":"10.1111\/dth.14312","article-title":"Management of pernio-like cutaneous manifestations in children during the outbreak of COVID-19","volume":"33","author":"Gallizzi","year":"2020","journal-title":"Dermatol Ther."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e13516","DOI":"10.1111\/dth.13516","article-title":"Chilblain-like lesions in pediatrics dermatological outpatients during the COVID-19 outbreak","volume":"33","author":"Garcia-Lara","year":"2020","journal-title":"Dermatol Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/PAS.0000000000001634","article-title":"Spectrum of clinicopathologic findings in COVID-19-induced skin lesions: demonstration of direct viral infection of the endothelial cells","volume":"45","author":"Garrido Ruiz","year":"2021","journal-title":"Am J Surg Pathol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/ijd.14974","article-title":"Chilblains-like dermatologic manifestation of COVID-19 diagnosed by serology via multidisciplinary virtual care","volume":"59","author":"Kerber","year":"2020","journal-title":"Int J Dermatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/pde.14257","article-title":"Rash as a presenting complaint in a child with COVID-19","volume":"37","author":"Klimach","year":"2020","journal-title":"Pediatr Dermatol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"E804","DOI":"10.1503\/cmaj.201348","article-title":"SARS-CoV-2-related chilblains","volume":"192","author":"Ladha","year":"2020","journal-title":"CMAJ."},{"key":"B30","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/ijd.14937","article-title":"Chilblain-like lesions on feet and hands during the COVID-19 pandemic","volume":"59","author":"Landa","year":"2020","journal-title":"Int J Dermatol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e365","DOI":"10.1111\/jdv.16617","article-title":"Histologic features of long-lasting chilblain-like lesions in a paediatric COVID-19 patient","volume":"34","author":"Locatelli","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e9245","DOI":"10.7759\/cureus.9245","article-title":"Chilblains in COVID-19 Infection","volume":"12","author":"Mohan","year":"2020","journal-title":"Cureus."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e357","DOI":"10.1111\/jdv.17194","article-title":"Chilblains in a child with confirmed SARS-CoV-2 infection: a red flag for late-onset skin manifestation in previously infected individuals","volume":"35","author":"Neri","year":"2021","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e783","DOI":"10.1111\/jdv.16881","article-title":"Acral skin eruption observed during SARS-CoV-2 pandemic: possible keratolysis exfoliativa with red palms and soles","volume":"34","author":"Neri","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1111\/jdv.16751","article-title":"Major cluster of paediatric 'true' primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown","volume":"34","author":"Neri","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"101707","DOI":"10.1016\/j.foot.2020.101707","article-title":"Foot manifestations in a patient with COVID-19 and Epstein-Barr virus: a case study","volume":"46","author":"Nirenberg","year":"2021","journal-title":"Foot (Edinb)."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/ped.14568","article-title":"Skin manifestations during the COVID-19 pandemic in the pediatric emergency department","volume":"63","author":"Rodr\u00edguez-Pastor","year":"2021","journal-title":"Pediatr Int."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e113760","DOI":"10.5812\/aapm.113760","article-title":"COVID-19 related acro-ischemic neuropathic-like painful lesions in pediatric patients: a case series","volume":"11","author":"Papa","year":"2021","journal-title":"Anesth Pain Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.jaad.2020.07.058","article-title":"Dermoscopy of chilblain-like lesions during the COVID-19 outbreak: a multicenter study on 10 patients","volume":"83","author":"Piccolo","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.11604\/pamj.supp.2020.35.2.24980","article-title":"Delayed hypersensitivity as a pathophysiological mechanism in cutaneous lesions due to SARS-CoV-2","volume":"35","author":"Rafai","year":"2020","journal-title":"Pan Afr Med J"},{"key":"B41","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1001\/jamadermatol.2020.2340","article-title":"Assessment of Acute Acral Lesions in a Case Series of Children and Adolescents During the COVID-19 Pandemic","volume":"156","author":"Roca-Gin\u00e9s","year":"2020","journal-title":"JAMA Dermatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s12519-020-00390-0","article-title":"Acral lesions in a pediatric population during the COVID-19 pandemic: a case series of 36 patients from a single hospital in Spain","volume":"16","author":"Ros\u00e9s-Gibert","year":"2020","journal-title":"World J Pediatr."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e689","DOI":"10.1111\/jdv.16776","article-title":"Recent outbreak of chilblain-like lesions is not directly related to SARS-CoV-2 infection","volume":"34","author":"Rouanet","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e13616","DOI":"10.1111\/dth.13616","article-title":"Therapy for probable COVID-19 associated erythema pernio-like lesions in pediatric age","volume":"33","author":"Ruggiero","year":"2020","journal-title":"Case report Dermatol Ther."},{"key":"B45","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/DAD.0000000000001825","article-title":"Cutaneous endothelial dysfunction and complement deposition in COVID-19","volume":"43","author":"Tammaro","year":"2021","journal-title":"Am J Dermatopathol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/ced.14267","article-title":"Skin signs resembling vascular acrosyndromes during the COVID-19 outbreak in Italy","volume":"45","author":"Tosti","year":"2020","journal-title":"Clin Exp Dermatol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jdin.2021.05.005","article-title":"Immunologic skin signatures in SARS-CoV-2-negative patients with chilblain-like lesions","volume":"4","author":"Vastarella","year":"2021","journal-title":"JAAD Int."},{"key":"B48","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.annder.2020.11.005","article-title":"Acute acral eruptions in children during the COVID-19 pandemic: characteristics of 103 children and their family clusters","volume":"148","author":"Hubiche","year":"2021","journal-title":"Ann Dermatol Venereol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1111\/bjd.19348","article-title":"Chilblain-like lesions during the COVID-19 pandemic: a serological study on a case series","volume":"183","author":"Rizzoli","year":"2020","journal-title":"Br J Dermatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.clindermatol.2020.12.008","article-title":"COVID-19: The experience from Italy","volume":"39","author":"Recalcati","year":"2021","journal-title":"Clin Dermatol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1111\/jdv.16682","article-title":"A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection","volume":"34","author":"El Hachem","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1001\/jamadermatol.2020.2368","article-title":"Evaluation of chilblains as a manifestation of the COVID-19 pandemic","volume":"156","author":"Herman","year":"2020","journal-title":"JAMA Dermatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/1742-6723.13630","article-title":"COVID. toes in stay-at-home adolescents: an epiphenomenon?","volume":"32","author":"Kluckow","year":"2020","journal-title":"Emerg Med Australas."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.jdcr.2020.09.024","article-title":"A new dermoscopic pattern for chilblain-COVID-19-like skin lesions in adolescents","volume":"6","author":"Fabbrocini","year":"2020","journal-title":"JAAD Case Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/pde.14269","article-title":"Chilblains in children in the time of COVID-19: New evidence with serology assay","volume":"37","author":"Colonna","year":"2020","journal-title":"Pediatr Dermatol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.annder.2020.12.002","article-title":"Cutaneous manifestations of COVID-19 in the Franche-Comt\u00e9 region of France: a monocentric study","volume":"148","author":"Jacquin-Porretaz","year":"2021","journal-title":"Ann Dermatol Venereol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/bjd.19493","article-title":"Response to 'No evidence of SARS-CoV-2 infection by polymerase chain reaction or serology in children with pseudo-chilblain'","volume":"183","author":"Recalcati","year":"2020","journal-title":"Br J Dermatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"10482","DOI":"10.3390\/ijerph181910482","article-title":"Nonfreezing cold injury (Trench Foot)","volume":"18","author":"Zafren","year":"2021","journal-title":"Int J Environ Res Public Health."},{"key":"B59","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/jpc.12094","article-title":"Major cluster of chilblain cases in a cold dry Western Australian winter","volume":"49","author":"Larkins","year":"2013","journal-title":"J Paediatr Child Health."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3000","DOI":"10.4049\/jimmunol.2001407","article-title":"Surface proteins of SARS-CoV-2 drive airway epithelial cells to induce IFN-dependent inflammation","volume":"206","author":"Anand","year":"2021","journal-title":"J Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"e3402","DOI":"10.1002\/dmrr.3402","article-title":"The implications of COVID-19 infection on the endothelium: a metabolic vascular perspective","volume":"37","author":"Dalan","year":"2021","journal-title":"Diabetes Metab Res Rev."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/bjd.20707","article-title":"Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak","volume":"185","author":"Frumholtz","year":"2021","journal-title":"Br J Dermatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1111\/ced.14586","article-title":"Chilblains and COVID-19: can recent epidemiological data shed light on the aetiological debate?","volume":"46","author":"Baeck","year":"2021","journal-title":"Clin Exp Dermatol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/jamapediatrics.2021.2482","article-title":"Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: a meta-analysis","volume":"175","author":"Racine","year":"2021","journal-title":"JAMA Pediatr."},{"key":"B65","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12969-016-0090-8","article-title":"Pediatric complex regional pain syndrome: a review","volume":"14","author":"Weissmann","year":"2016","journal-title":"Pediatr Rheumatol Online J."},{"key":"B66","doi-asserted-by":"publisher","first-page":"h2730","DOI":"10.1136\/bmj.h2730","article-title":"Complex regional pain syndrome","volume":"351","author":"Bruehl","year":"2015","journal-title":"BMJ"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.904616\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T06:17:55Z","timestamp":1655965075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.904616\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":66,"alternative-id":["10.3389\/fped.2022.904616"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.904616","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"article-number":"904616"}}